Michael R. Barer
- Endocrinology top 0.5%
- Vibrio bacteria research studies 12
- Infectious Diseases top 0.5%
- Tuberculosis Research and Epidemiology 31
- Molecular Medicine top 1%
- Emergency Medical Services top 0.5%
- Pediatric health and respiratory diseases 10
- Epidemiology top 1%
- Mycobacterium research and diagnosis 31
- Pneumonia and Respiratory Infections 11
-
- Healthcare Policy and Management 15
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 14
-
- Bacteriophages and microbial interactions 13
- Co-authors
- Colin R. HarwoodChristopher E. BrightlingMona BafadhelNatalie J. GartonDieter WeichartArseny S. KaprelyantsDouglas B. KellP.T. Kimmitt
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nucleic Acids Research (1 paper)Nature Communications (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Michael R. Barer
155 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 186
- Endocrinology 824
- Infectious Diseases 1.8k
- Molecular Medicine 366
- Emergency Medical Services 404
- Epidemiology 1.7k
Countries citing papers authored by Michael R. Barer
This map shows the geographic impact of Michael R. Barer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Barer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Barer more than expected).
Fields of papers citing papers by Michael R. Barer
This network shows the impact of papers produced by Michael R. Barer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Barer. The network helps show where Michael R. Barer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael R. Barer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 21 | |
| 4 | 2022 | 14 | |
| 5 | 2020 | 143 | |
| 6 | 2020 | 83 | |
| 7 | 2020 | 0 | |
| 8 | 2018 | 6 | |
| 9 | 2015 | 15 | |
| 10 | Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease: A Randomized Placebo-Controlled Trialbreakdown → | 2012 | 422 |
| 11 | 2009 | 203 | |
| 12 | 2009 | 34 | |
| 13 | 2008 | 313 | |
| 14 | 2005 | 8 | |
| 15 | 2005 | 28 | |
| 16 | 2002 | 58 | |
| 17 | 1998 | 458 | |
| 18 | Common Problems, Different "Solutions": Learningfrom International Approaches to Improving MedicalServices Access for Underserved Populations | 1997 | 1 |
| 19 | 1997 | 1 | |
| 20 | 1992 | 11 |
About Michael R. Barer
Michael R. Barer is a scholar working on Medical Terminology, Endocrinology and Infectious Diseases, having authored 169 papers that have together received 6.9k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (31 papers), Mycobacterium research and diagnosis (31 papers), Healthcare Policy and Management (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers), Bacteriophages and microbial interactions (13 papers), Vibrio bacteria research studies (12 papers), Pneumonia and Respiratory Infections (11 papers) and Pediatric health and respiratory diseases (10 papers). The work is most often cited by research in Endocrinology (824 citations), Infectious Diseases (1.8k citations) and Molecular Medicine (366 citations). Michael R. Barer has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Colin R. Harwood, Christopher E. Brightling, Mona Bafadhel, Natalie J. Garton, Dieter Weichart, Arseny S. Kaprelyants, Douglas B. Kell, P.T. Kimmitt, Rory P. Cooney and Richard A. Adegbola. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.